Unsuccessful high dose IL-2 therapy followed immediately by near continuous low dose temozolomide can result in rapid durable complete and near-complete remissions in metastatic melanoma

Salman Fateh, Todd D. Schell, Rebecca Gingrich, Rogerio I. Neves, Joseph J. Drabick

Research output: Contribution to journal › Article › peer-review

9 Scopus citations

Fingerprint

Dive into the research topics of 'Unsuccessful high dose IL-2 therapy followed immediately by near continuous low dose temozolomide can result in rapid durable complete and near-complete remissions in metastatic melanoma'. Together they form a unique fingerprint.

Medicine & Life Sciences